Intravenous Tranexamic Acid

Summary

Tranexamic acid is a promising option for minimizing blood loss in high-risk bariatric surgery patients, particularly in those with obesity, diabetes, and other comorbidities. When used appropriately, TXA can reduce the need for blood transfusions, maintain hemodynamic stability, and lower the incidence of complications related to blood loss.

Timeline

Start

2025-10-15

Primary completion

2026-02-15

Completion

2026-03-30

Drugs

Indications